SpinX

About:

SpinX designs and develops products which exploit its innovative adaptive microfludics technology.

Website: http://www.spinx-technologies.com/

Top Investors: Index Ventures, Auriga Partners, ePlanet Capital, BioFund Management

Description:

SpinX develops and commercializes a programmable lab-on-a-chip platform for applications that ranges from drug discovery to consumer diagnostics. Its products include SpinX Lab, a system to transition from low volume microplate assays to an automated bench-top technology for assays in nanoliter volumes; and workflow, an assay preparation for a panel of enzymatic assays. Bart Van de Vyver and Piero Zucchelli founded SpinX in 2003. It has its headquarters in Geneva in Switzerland.